75 related articles for article (PubMed ID: 16890208)
1. Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases.
Hurd CA; Brear P; Revell J; Ross S; Mott HR; Owen D
J Biol Chem; 2021; 296():100101. PubMed ID: 33214225
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis.
Sun T; Zhang P; Zhang Q; Wang B; Zhao Q; Liu F; Ma X; Zhao C; Zhou X; Chen R; Ouyang S
Heliyon; 2024 May; 10(10):e30780. PubMed ID: 38765024
[TBL] [Abstract][Full Text] [Related]
3. Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels.
Hindle A; Bose C; Lee J; Palade PT; Peterson CJ; Reddy PH; Awasthi S; Singh SP
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158795
[TBL] [Abstract][Full Text] [Related]
4. Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer.
Sadeghi MM; Salama MF; Hannun YA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073823
[TBL] [Abstract][Full Text] [Related]
5. A potential function of RLIP76 in the ovarian corpus luteum.
Billhaq DH; Lee S
J Ovarian Res; 2019 Apr; 12(1):34. PubMed ID: 30999946
[TBL] [Abstract][Full Text] [Related]
6. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer.
Singhal J; Nagaprashantha L; Chikara S; Awasthi S; Horne D; Singhal SS
Oncotarget; 2017 Sep; 8(43):75025-75037. PubMed ID: 29088842
[TBL] [Abstract][Full Text] [Related]
7. Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.
Goldfinger LE; Lee S
Lung Cancer (Auckl); 2013; 2013(4):61-69. PubMed ID: 25419163
[TBL] [Abstract][Full Text] [Related]
8. RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients.
Manguoğlu E; Akdeniz S; Dündar N; Duman O; Aktekin B; Haspolat S; Bilge U; Ozel D; Lüleci G
Balkan J Med Genet; 2011 Jun; 14(1):25-30. PubMed ID: 24052699
[TBL] [Abstract][Full Text] [Related]
9. Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.
Singhal SS; Wickramarachchi D; Yadav S; Singhal J; Leake K; Vatsyayan R; Chaudhary P; Lelsani P; Suzuki S; Yang S; Awasthi YC; Awasthi S
Mol Cancer Ther; 2011 Jan; 10(1):16-28. PubMed ID: 21220488
[TBL] [Abstract][Full Text] [Related]
10. RLIP76: a versatile transporter and an emerging target for cancer therapy.
Vatsyayan R; Lelsani PC; Awasthi S; Singhal SS
Biochem Pharmacol; 2010 Jun; 79(12):1699-705. PubMed ID: 20097178
[TBL] [Abstract][Full Text] [Related]
11. Role of RLIP76 in doxorubicin resistance in lung cancer.
Vatsyayan R; Chaudhary P; Lelsani PC; Singhal P; Awasthi YC; Awasthi S; Singhal SS
Int J Oncol; 2009 Jun; 34(6):1505-11. PubMed ID: 19424567
[TBL] [Abstract][Full Text] [Related]
12. RLIP76: A novel glutathione-conjugate and multi-drug transporter.
Singhal SS; Yadav S; Roth C; Singhal J
Biochem Pharmacol; 2009 Mar; 77(5):761-9. PubMed ID: 18983828
[TBL] [Abstract][Full Text] [Related]
13. RLIP76 in defense of radiation poisoning.
Singhal J; Singhal SS; Yadav S; Suzuki S; Warnke MM; Yacoub A; Dent P; Bae S; Sharma R; Awasthi YC; Armstrong DW; Awasthi S
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):553-61. PubMed ID: 18793957
[TBL] [Abstract][Full Text] [Related]
14. Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.
Singhal SS; Yadav S; Singhal J; Sahu M; Sehrawat A; Awasthi S
FEBS Lett; 2008 Oct; 582(23-24):3408-14. PubMed ID: 18789326
[TBL] [Abstract][Full Text] [Related]
15. RLIP76 and Cancer.
Awasthi S; Singhal SS; Awasthi YC; Martin B; Woo JH; Cunningham CC; Frankel AE
Clin Cancer Res; 2008 Jul; 14(14):4372-7. PubMed ID: 18628450
[TBL] [Abstract][Full Text] [Related]
16. Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.
Singhal SS; Yadav S; Drake K; Singhal J; Awasthi S
J Biol Chem; 2008 Jul; 283(28):19714-29. PubMed ID: 18474607
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.
Singhal SS; Yadav S; Singhal J; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2006 Sep; 348(2):722-7. PubMed ID: 16890208
[TBL] [Abstract][Full Text] [Related]
18. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
